Press Releases
Well prepared for the revision of the EU GMP Annex 1
The Annex 1 of the EU GMP Guide "Manufacture of Sterile Medicinal Products" is considered the most important European regulatory standard for the manufacture of...
Press Releases
EMC Szpitale, Poland, brings access to innovative treatments to its patients by joining Clinerion’s Patient Network Explorer platform
EMC Szpitale augments Clinerion’s patient coverage in Poland by joining the Patient Network Explorer platform. Patients at the hospital group will gain greater access to...
Press Releases
InSyBio Suite V2.5 has been launched and includes for the first time a complete pipeline for the analysis of RNA-sequencing data
The new version of InSyBio Suite enables the fast and accurate discovery of transcriptomics predictive biomarkers. The newly introduced pipeline...
Press Releases
Codexis Announces CodeEvolver Technology Transfer and License Agreement with Global Pharmaceutical Leader
Codexis, Inc , a leading protein engineering company, announces the signing of a CodeEvolver® platform agreement with Novartis. Under the terms of...
Press Releases
CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’
CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says...
Press Releases
Inpharamo will facilitate the entry of Clinerion into the Mexican clinical research market
Semicrol will facilitate the entry of Clinerion into Mexico through its subsidiary Inpharamo. Inpharamo’s network of contacts will serve as the gateway for the Swiss...
Press Releases
Recipharm launches Recipharm Inhalation SolutionsTM as its end-to-end offering for inhalation products
Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.